We are proud to celebrate the work of Ms. Shen Yating, a Research Assistant from the Translational Core Laboratory at WisDM/N.1, who has been shortlisted to deliver a Lightning Talk at the Frontiers in Cancer Science (FCS) 2025 conference, held from 5 to 7 November 2025. Her presentation, “Dual inhibition of protein degradation and nuclear export uncovers molecular dependencies in Gliomas,” highlights mechanistic insights into the vulnerabilities of high-grade gliomas and represents an important step toward improving therapeutic strategies for these deadly cancers. Yating’s achievement reflects her dedication and the Translational Core Lab’s ongoing commitment to advancing the understanding and treatment of cancer through rigorous and impactful science.